Literature DB >> 30763444

Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors.

Jonathan Raphael Strosberg1, Taymeyah Al-Toubah1, Mauro Cives2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30763444     DOI： 10.1001/jamaoncol.2018.6694

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  1 in total

1.  Laboratory variables as predictors of progression in gastroenteropancreatic neuroendocrine tumors in different lines of antineoplastic treatments.

Authors:  Daniela Pezzutti Domigues Armentano; Mariana Ribeiro Monteiro; Pedro Nazareth Aguiar; Jessica Sayuri Tsukamoto; Raquel Baptista Pio; Renata Arakelian; Raphael Leonardo Cunha Araujo; Pedro Luiz Serrano Usón Junior
Journal:  Einstein (Sao Paulo)       Date:  2022-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.